SF-36
SF-36 or The Short Form (36) Health Survey is a patient-reported health measure that assesses health-related quality of life in 8 areas: 1) limitations in physical activities because of health problems; 2) limitations in social activities because of physical or emotional problems; 3) limitations in usual role activities because of physical health problems; 4) bodily pain; 5) general mental health; 6) limitations in usual role activities because of emotional problems; 7) vitality (energy and fatigue); and 8) general health perceptions.[1] A score of zero represents completely disability, and a score of 100 no disability.
SF-36 was used in the PACE trial and many other ME/CFS trials, such as the CDC's Wichita Clinical Study[2] and the Ampligen AMP-516 clinical trial.[3]
Studies[edit | edit source]
- 2016, The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
"RESULTS: The general and physical fatigue subscales on Multidimensional Fatigue Inventory-20, as well as the role of physical health on the RAND SF-36, demonstrated questionable or unacceptable internal consistency and problematic ceiling effects. The DePaul Symptom Questionnaire demonstrated excellent internal reliability, and less than 5 % of participants were at the ceiling on each subscale. The post-exertional malaise subscale on the DePaul Symptom Questionnaire demonstrated excellent clinical utility as it was able to differentiate between ME/CFS patients and controls (OR 1.23, p < .001) and predicted ceiling effects on other patient-reported outcome subscales. A score of 20 on the post-exertional malaise subscale of the DePaul Symptom Questionnaire optimally differentiated between patients and controls."[4]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ http://www.cdc.gov/cfs/pdf/wichita-data-access/sf36-doc.pdf
- ↑ http://www.cdc.gov/cfs/programs/wichita-data-access/
- ↑ http://simmaronresearch.com/category/ampligen/
- ↑ Murdock, KW; Wang, XS; Shi, Q; Cleeland, CS; Fagundes, CP; Vernon, Suzanne D. (2016), "The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.", Quality of Life Research, doi:10.1007/s11136-016-1406-3, PMID 27600520